inPractice provides insight and practical recommendations for HIV patient care.
Subject Matter: HIV
Physicians and other healthcare professionals including:
• Infectious disease specialists
• Primary care practitioners managing patients with HIV
• Other specialists managing patients with HIV
• Nurses, nurse practitioners, and physician assistants caring for patients with HIV
• Expert-authored, comprehensive HIV reference work
• Continuously updated to incorporate latest findings and best practices
• Complete drug database (by Lexi-Comp; includes all FDA-approved drugs)
• Practice guidelines
• Relevant PubMed abstracts (MEDLINE)
In Practice—Not Just in Theory
Translates the constant stream of latest developments in HIV into clinically applicable information.
• Search and find targeted recommendations for your patient care questions
• Know that the evidence supports your decisions
Integrates insightful Conference Coverage, drug developments, journal citations, and guidelines to keep you abreast of the developments you can apply to practice.
Education With Relevance
Earn CME credit for the topics you’re searching anyway. (To claim credit, just visit the free, companion Web site.)
• Easily share information with colleagues or trainees
• Integrated bookmark function for quick return access to key topics
• Companion Web site included
How to Gain Access:
Free, one-time registration or use your existing Clinical Care Options member ID. (Your information will not be shared or sold to third parties.)
The glossary app includes the following features:
• Toggle button to switch between English and Spanish terms and definitions
• Audio feature to hear correct pronunciation of terms in English and Spanish
• "Random" button that signals the app to display a randomly selected term and definition
AIDSinfo, a service of the U.S. Department of Health and Human Services (HHS), offers health care providers and consumers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other HIV-related research information. AIDSinfo is collectively sponsored by the Office of AIDS Research (OAR), the National Institute of Allergy and Infectious Diseases (NIAID), and the National Library of Medicine (NLM)—three entities within the National Institutes of Health (NIH); the Health Resources and Services Administration (HRSA); and the Centers for Disease Control and Prevention (CDC).
HIV infection in humans is considered pandemic by the World Health Organization (WHO). Nevertheless, complacency about HIV may play a key role in HIV risk. From its discovery in 1981 to 2006, AIDS killed more than 25 million people. HIV infects about 0.6% of the world's population. In 2005, AIDS claimed an estimated 2.4–3.3 million lives, of which more than 570,000 were children. A third of these deaths occurred in Sub-Saharan Africa, retarding economic growth and increasing poverty. At that time, it was estimated that HIV would infect 90 million people in Africa, resulting in a minimum estimate of 18 million orphans. Antiretroviral treatment reduces both the mortality and the morbidity of HIV infection, but routine access to antiretroviral medication is not available in all countries.
HIV infects primarily vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through three main mechanisms: First, direct viral killing of infected cells; second, increased rates of apoptosis in infected cells; and third, killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections.
Most untreated people infected with HIV-1 eventually develop AIDS. These individuals mostly die from opportunistic infections or malignancies associated with the progressive failure of the immune system. HIV progresses to AIDS at a variable rate affected by viral, host, and environmental factors; most will progress to AIDS within 10 years of HIV infection: some will have progressed much sooner, and some will take much longer. Treatment with anti-retrovirals increases the life expectancy of people infected with HIV. Even after HIV has progressed to diagnosable AIDS, the average survival time with antiretroviral therapy was estimated to be more than 5 years as of 2005. Without antiretroviral therapy, someone who has AIDS typically dies within a year.
- Browse Knowledge Base of HIV/AIDS related topics
- Ask our experts your HIV/AIDS-related questions
- View promotional videos
- View photo albums from recent events
- Get up-to-the-minute notifications of HIV/AIDS related news & events
- Find HIV/AIDS testing centres in your area
Anti-HIV Med is developed by the HIV Research Team at Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong as an independent tool. This is also currently accessible as a supplement appended to HIV Manual 3rd Edition.
Compiled over the years by e-med Private Medical Services, the database is intended as a guide for medical inquiry and is not intended to be used as a diagnostic tool. All medical complaints should be referred to a healthcare professional.
-Disease Description. A clear and concise description of the disease including pathophysiology, incidence, complications and causes. Information is presented in a simple easy to understand format without sacrificing accuracy or detail. Explanations of disease processes are assisted by the appropriate use of illustrations and diagrams.
-Signs and Symptoms. A complete description of all the signs and symptoms associated with each disease.
-Investigations. A detailed list of recommended investigations which may be used to make a diagnosis. This includes laboratory tests, radiography, imaging, surgery and all other relevant investigations
-Treatment. A comprehensive and detailed description of current recommended treatments, including dosages for most medications
-Patient Management. Things the patient can do to assist in treatment where applicable.
Most medical information accessible to the general public is either over simplified and of questionable value, or too complicated to understand. The objective when compiling this encyclopaedia was too strike a middle ground, so that the information was presented in a way that could be understood by the general public and contained enough accurate and detailed information to satisfy health care providers or members of the medical profession.
This software was designed to assist members of the public with their healthcare by providing easy access to an accurate source of comprehensible medical information. Other individuals or groups which would benefit from the use of this software include;
-Patients with an exiting medical condition can access simple detailed illustrated explanations of their condition with the click of a button. They can also obtain information on the appropriate diagnostic tests and procedures which should be used to confirm the diagnosis and check their medication in the treatment section.
-Patients who are newly diagnosed will be better able to understand their condition and will be well informed about upcoming diagnostic tests and procedures and the different forms of treatment currently available.
-Medical practitioners can refresh their memory from the 400+ diseases in the database or quickly obtain a list of recommended diagnostic tests or procedures.
-Allied health professionals can use the software to quickly obtain simple accurate and detailed descriptions of medical conditions they may not be familiar with so that they can better contribute to patient care
-Medical students can gain rapid access to a vast collection of readily available medical information at a fraction of the cost of medical text books. They will also appreciate the simple yet detailed disease descriptions, with coloured illustrations and the comprehensive list of diagnostic tests and treatments.
All of the medical data used to compile this software was extracted, cross-referenced or summarised from a number of highly reputable sources including:
-Harrison's Principles of Internal Medicine 16th Edit.
-The Merck Manual 18th Edit.
-Oxford Handbook of Clinical Medicine 6th Edit.
-Murtagh's General Practice
If you want high quality, accurate up to date medical information at your finger tips, download this app now
Test your medical knowledge in multiple ways – try it based on medical specialty, cardiovascular, neurological and more. eMedicineQuiz presently covers 7 specialties. Or try it body region wise. Want to try another flavor? Try out symptoms, diagnoses, tests and treatments or mix them all up. Track your score, share your questions, analyze your weaknesses. eMedicineQuiz is released with a 1000 clinically relevant questions with 1000s more to come.
The Johns Hopkins HIV Guide delivers the latest authoritative clinical decision support information on the diagnosis, management, and relevant medications to clinicians’ fingertips.
Clinicians can consult this specialized guide, written and updated by experts at the Johns Hopkins University School of Medicine, to find answers fast at the point of care. The guide contains information on opportunistic infections, malignancies, complications, related rugs, pathogens, therapy guidelines, and a resistance tool.
The Johns Hopkins HIV Guide is arranged in a way that lets clinicians easily browse or search for content. Each entry is easy to navigate and contains the most important information to help clinicians quickly make decisions.
With the Johns Hopkins HIV Guide you can:
• Review in-depth coverage of HIV therapy including infections, malignancies, clinical tests, microbiology, and treatment options.
• Find the latest medications available for each condition with expert drug comments.
• Access medical literature with reference links within each entry.
• Coverage of complications of treatment
• Drug listings with adverse reactions and interactions
• Management options and clinical recommendations
• Diagnosis and Pathogen indices
• Universal Index Search – find topics across all indexes
• Personalized favorites
Editors: Joel E. Gallant, MD, MPH; Paul Pham, PharmD, BCPS
Publisher: Johns Hopkins Medicine
Powered by: Unbound Medicine
This Manual is the third edition involving the contribution of 32 reviewer-authors drawn from The Chinese University of Hong Kong, The University of Hong Kong, Department of Health Integrated Treatment Centre, Social Hygiene Service and Tuberculosis and Chest Service, as well as three HIV services under Hospital Authority – Queen Elizabeth Hospital, Princess Margaret Hospital, and Prince of Wales Hospital.
- Chapters are grouped under 6 sections – basics of HIV medicine, public health management, clinical management, opportunistic and concurrent infections, neoplasia, Special settings & the community.
- Algorithms continue to be a key component in many chapters.
- References are linked to the sources.
- Link to interactive tool giving useful information of each registered antiretroviral compound, from its basic characteristics, formulation, dosage to side effects and cautions for prescribing doctors.
- All important local guidelines on HIV management are appendiced. This is important for frontline professionals as a one-stop resource when it comes to HIV management.
- An HIV/AIDS Report form can be downloaded.
- Local perspective to HIV management.
- Also useful to students in medicine, nursing, public health and other health care subjects.
Editor and Project Coordinator
Shui Shan LEE
Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong
O aplicativo apresenta profilaxia para doenças oportunistas assim como o tratamento e profilaxia secundária.
A maioria da recomendações são baseadas no protocolo clínico do ministério da saúde do Brasil e outros guidelines internacionais.
1. Distress call for ground and air ambulance evacuation
2. Doctors contact information
3. Pharmacy contact information
4. GPS locator to Jamaica’s Hospitals and Clinics
For HIV In Children, registration is required on www.hivinchildren.org to log in and use this tool.
*Data services are required to access all sections of the application.
*Supports API levels 8 & above (Android 2.2 and above)
TAGS: hiv, children, hiv in children, grand rounds, ask doctor, pediatriconcall
This application has been developed for exclusive use by health professionals. If you are not biomedical personnel you should not download this application.
Management of HIV and viral hepatitis infections are ever-changing fields and
resistance to antiviral agents represents one major issue for the management of infected
This application provides instant and easy access to regularly updated information about
specific HIV, HCV and HBV mutations related to resistance to antiviral drugs. Both
in vitro and in vivo information is provided for each specific drug resistance mutation
selected by users.
This is an “offline” application that is downloaded to your device. An internet
connection is not required to use the application.
The application has been developed by Lluita contra la Sida Foundation through support
from MSD, Gilead and BMS.
More from developer
This is an “offline” application that is downloaded to your device (~350kb). An internet connection is not required to use the application, but is needed for downloading updates.
Why this application may be useful:
In hepatitis therapy, patients take more than one hepatitis medication at a time and possibly other drugs to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different hepatitis drugs and other medications that the HCV- and/or HBV-infected patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.hep-druginteractions.org.